We are live on ! Find out more
HA

HHLR Advisors Portfolio holdings

AUM $1.67B
1-Year Est. Return 7.53%
This Fund
S&P 500
This Quarter Est. Return
+32.04%
1 Year Est. Return
+7.53%
3 Year Est. Return
+82.23%
5 Year Est. Return
+55.28%
10 Year Est. Return
AUM
$13.2B
AUM Growth
+$2.26B
Cap. Flow
-$216M
Cap. Flow %
-1.63%
Top 10 Hldgs %
73.1%
Holding
94
New
20
Increased
11
Reduced
12
Closed
5

Top Buys

Rank Stock Value
1
JD icon
JD.com
JD
+$569M
2
BEKE icon
KE Holdings
BEKE
+$250M
3
GDS icon
GDS Holdings
GDS
+$246M
4
SNOW icon
Snowflake
SNOW
+$100M
5
CRM icon
Salesforce
CRM
+$61M

Top Sells

Rank Stock Value
1
ZM icon
Zoom
ZM
+$590M
2
TAL icon
TAL Education Group
TAL
+$286M
3
BILI icon
Bilibili
BILI
+$224M
4
IQ icon
iQIYI
IQ
+$162M
5
TSLA icon
Tesla
TSLA
+$141M

Sector Composition

Rank Sector Weight
1 Technology 28.22%
2 Consumer Discretionary 25.68%
3 Healthcare 25.59%
4 Communication Services 8.49%
5 Consumer Staples 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEAM icon
26
Beam Therapeutics
BEAM
$2.71B
$73M 0.55%
2,966,403
NBP
27
NovaBridge Biosciences American Depositary Shares
NBP
$191M
$70.4M 0.53%
+1,496,540
New +$49.3M
VIE
28
DELISTED
Viela Bio, Inc. Common Stock
VIE
$69.6M 0.53%
2,477,631
-338,237
-12% -$12M
GMAB icon
29
Genmab
GMAB
$17.5B
$54.9M 0.42%
1,500,000
NIO icon
30
NIO
NIO
$12B
$51.2M 0.39%
+2,411,750
New +$37.1M
AKRO
31
DELISTED
Akero Therapeutics
AKRO
$51M 0.39%
1,656,673
+600,000
+57% +$21M
KNSA icon
32
Kiniksa Pharmaceuticals
KNSA
$6.19B
$44.7M 0.34%
2,920,023
+476,190
+19% +$8.94M
NVAX icon
33
Novavax
NVAX
$1.21B
$41.7M 0.32%
385,158
+59,120
+18% +$7.2M
OTIS icon
34
Otis Worldwide
OTIS
$27.9B
$38.4M 0.29%
614,556
TSM icon
35
TSMC
TSM
$1.97T
$32.5M 0.25%
400,495
-700,000
-64% -$53.2M
Z icon
36
Zillow
Z
$7.78B
$30.7M 0.23%
+302,336
New +$23.6M
ALLO icon
37
Allogene Therapeutics
ALLO
$614M
$30.2M 0.23%
800,000
MELI icon
38
Mercado Libre
MELI
$94.4B
$29.8M 0.23%
+27,525
New +$29.9M
LI icon
39
Li Auto
LI
$14.4B
$29.1M 0.22%
+1,670,931
New +$27.9M
MLCO icon
40
Melco Resorts & Entertainment
MLCO
$2.21B
$28.3M 0.21%
1,698,877
IGMS
41
DELISTED
IGM Biosciences
IGMS
$25.8M 0.2%
350,000
BEDU
42
DELISTED
Bright Scholar Education Holdings
BEDU
$25.5M 0.19%
996,449
FMTX
43
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$24.9M 0.19%
500,000
MOGU
44
MOGU Inc
MOGU
$17.3M
$24.6M 0.19%
870,581
AMG icon
45
Affiliated Managers Group
AMG
$9.64B
$22.9M 0.17%
335,073
PRLD icon
46
Prelude Therapeutics
PRLD
$364M
$22.6M 0.17%
+750,000
New +$21.2M
LEGN icon
47
Legend Biotech
LEGN
$3.65B
$20.1M 0.15%
650,000
JOYY
48
JOYY Inc
JOYY
$3.73B
$19.3M 0.15%
239,476
XPEV icon
49
XPeng
XPEV
$12.6B
$18.4M 0.14%
+916,518
New +$17.9M
NKTX icon
50
Nkarta
NKTX
$154M
$16.7M 0.13%
+555,556
New +$16.4M

Similar funds

HHLR Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, HHLR Advisors held 94 positions worth $13.2B, up 21% from $10.9B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

HHLR Advisors's Q3 2020 filing shows 20 new, 11 increased, 12 reduced and 5 closed positions. Its largest new stake was KE Holdings: 5,000,000 shares worth $307M. The largest sale was Zoom, an estimated $590M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • HHLR Advisors's largest Q3 2020 buy was KE Holdings: 5,000,000 shares worth $307M.
  • HHLR Advisors added most to JD.com in Q3 2020, an estimated $569M increase.
  • HHLR Advisors's biggest Q3 2020 reduction was Zoom, cutting an estimated $590M.
  • HHLR Advisors fully exited Tesla in Q3 2020, selling an estimated $141M.
  • HHLR Advisors's ten largest holdings make up 73% of its $13.2B portfolio in Q3 2020.
  • HHLR Advisors opened 20 new positions and closed 5 in Q3 2020.
  • HHLR Advisors's portfolio value rose 21% quarter-over-quarter to $13.2B.

Based on HHLR Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.